Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,725.00
+115.00 (3.19%)
Apr 1, 2025, 3:30 PM KST

Xcell Therapeutics Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Operating Revenue
1,9341,1241,0201,966540.2
Upgrade
Other Revenue
--0--
Upgrade
Revenue
1,9341,1241,0201,966540.2
Upgrade
Revenue Growth (YoY)
72.11%10.18%-48.12%264.00%531.11%
Upgrade
Cost of Revenue
3,3332,9872,7732,2841,641
Upgrade
Gross Profit
-1,399-1,863-1,753-318.08-1,101
Upgrade
Selling, General & Admin
4,3233,4003,2193,0581,819
Upgrade
Research & Development
2,7282,7532,5961,8321,166
Upgrade
Other Operating Expenses
36.0171.45140.2178.14.63
Upgrade
Operating Expenses
7,9317,0766,5465,3873,376
Upgrade
Operating Income
-9,330-8,939-8,299-5,705-4,477
Upgrade
Interest Expense
-4.4-3.12-2.89-179.78-827.41
Upgrade
Interest & Investment Income
201.2950.84114.0241.7515.12
Upgrade
Currency Exchange Gain (Loss)
12.842.5211.572.38-0.23
Upgrade
Other Non Operating Income (Expenses)
-295.6-257.58-165.59-3,186-4,838
Upgrade
EBT Excluding Unusual Items
-9,416-9,147-8,342-9,026-10,127
Upgrade
Gain (Loss) on Sale of Investments
2.72-0.87---
Upgrade
Gain (Loss) on Sale of Assets
-130.1321-0.53-123
Upgrade
Asset Writedown
--154.12---
Upgrade
Pretax Income
-9,543-9,281-8,342-9,038-10,124
Upgrade
Net Income
-9,543-9,281-8,342-9,038-10,124
Upgrade
Net Income to Common
-9,543-9,281-8,342-9,038-10,124
Upgrade
Shares Outstanding (Basic)
109984
Upgrade
Shares Outstanding (Diluted)
109984
Upgrade
Shares Change (YoY)
13.07%1.05%5.71%131.08%107.45%
Upgrade
EPS (Basic)
-954.00-1049.00-952.90-1091.40-2825.00
Upgrade
EPS (Diluted)
-954.00-1049.00-953.00-1091.40-2825.00
Upgrade
Free Cash Flow
-7,379-7,008-8,475-5,952-5,657
Upgrade
Free Cash Flow Per Share
-737.67-792.18-968.02-718.67-1578.43
Upgrade
Gross Margin
-72.30%-165.77%-171.89%-16.18%-203.76%
Upgrade
Operating Margin
-482.33%-795.37%-813.59%-290.14%-828.78%
Upgrade
Profit Margin
-493.36%-825.74%-817.85%-459.67%-1874.20%
Upgrade
Free Cash Flow Margin
-381.48%-623.58%-830.82%-302.69%-1047.18%
Upgrade
EBITDA
-7,677-7,341-6,786-4,686-3,795
Upgrade
EBITDA Margin
----238.34%-
Upgrade
D&A For EBITDA
1,6531,5981,5131,019681.79
Upgrade
EBIT
-9,330-8,939-8,299-5,705-4,477
Upgrade
EBIT Margin
----290.14%-
Upgrade
Advertising Expenses
154.72315.24267.87279.2597.97
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.